Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.72
(-5.28%)
CNY 7.72
(-5.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 449.24 Million CNY | -22.94% |
| 2022 | 524.78 Million CNY | 53.78% |
| 2021 | 389.7 Million CNY | -23.52% |
| 2020 | 513.92 Million CNY | 38.73% |
| 2019 | 334.75 Million CNY | 28.4% |
| 2018 | 282.05 Million CNY | 16.78% |
| 2017 | 238.97 Million CNY | 1.71% |
| 2016 | 234.12 Million CNY | 26.48% |
| 2015 | 185.27 Million CNY | 29.24% |
| 2014 | 142.87 Million CNY | 53.35% |
| 2013 | 92.61 Million CNY | 6.39% |
| 2012 | 86.5 Million CNY | 90.59% |
| 2011 | 46.03 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 49.91 Million CNY | 38.06% |
| 2024 Q2 | 74.77 Million CNY | -21.56% |
| 2024 Q3 | 77.7 Million CNY | -8.9% |
| 2023 Q4 | 56.24 Million CNY | 1158.25% |
| 2023 FY | - CNY | -22.94% |
| 2023 Q1 | 221.94 Million CNY | 155.15% |
| 2023 Q2 | 25.17 Million CNY | -88.66% |
| 2023 Q3 | -5.31 Million CNY | -121.11% |
| 2022 Q4 | 86.98 Million CNY | -47.62% |
| 2022 FY | - CNY | 53.78% |
| 2022 Q3 | 166.07 Million CNY | 600.53% |
| 2022 Q2 | -33.17 Million CNY | -137.82% |
| 2022 Q1 | 87.72 Million CNY | -21.58% |
| 2021 FY | - CNY | -23.52% |
| 2021 Q2 | -11.6 Million CNY | -119.24% |
| 2021 Q3 | -38.94 Million CNY | -235.56% |
| 2021 Q1 | 60.31 Million CNY | -28.9% |
| 2021 Q4 | 111.87 Million CNY | 387.27% |
| 2020 Q1 | 95.73 Million CNY | 26.71% |
| 2020 Q3 | 88.74 Million CNY | 3747.85% |
| 2020 Q2 | 2.3 Million CNY | -97.59% |
| 2020 FY | - CNY | 38.73% |
| 2020 Q4 | 84.83 Million CNY | -4.41% |
| 2019 Q3 | 6.3 Million CNY | 617.07% |
| 2019 Q2 | -1.21 Million CNY | -101.42% |
| 2019 Q1 | 85.82 Million CNY | 429.34% |
| 2019 FY | - CNY | 28.4% |
| 2019 Q4 | 75.55 Million CNY | 1098.28% |
| 2018 Q3 | 77.51 Million CNY | 346.16% |
| 2018 FY | - CNY | 16.78% |
| 2018 Q1 | 75.61 Million CNY | -11.51% |
| 2018 Q4 | 16.21 Million CNY | -79.08% |
| 2018 Q2 | -31.48 Million CNY | -141.64% |
| 2017 Q1 | 33.79 Million CNY | -41.57% |
| 2017 FY | - CNY | 1.71% |
| 2017 Q3 | 26.43 Million CNY | -16.57% |
| 2017 Q4 | 85.44 Million CNY | 223.27% |
| 2017 Q2 | 31.68 Million CNY | -6.26% |
| 2016 Q3 | 38.61 Million CNY | 805.8% |
| 2016 FY | - CNY | 26.48% |
| 2016 Q4 | 57.83 Million CNY | 49.79% |
| 2016 Q2 | -5.47 Million CNY | -106.4% |
| 2016 Q1 | 85.54 Million CNY | 46.21% |
| 2015 Q2 | -83.83 Million CNY | -164.74% |
| 2015 Q1 | 129.49 Million CNY | 187.45% |
| 2015 FY | - CNY | 29.24% |
| 2015 Q4 | 58.5 Million CNY | 98.05% |
| 2015 Q3 | 29.54 Million CNY | 135.24% |
| 2014 FY | - CNY | 53.35% |
| 2014 Q3 | 21.55 Million CNY | 126.82% |
| 2014 Q1 | 114.29 Million CNY | 0.0% |
| 2014 Q4 | 45.04 Million CNY | 109.04% |
| 2014 Q2 | -80.35 Million CNY | -170.3% |
| 2013 FY | - CNY | 6.39% |
| 2012 FY | - CNY | 90.59% |
| 2011 FY | - CNY | 0.0% |